期刊文献+

Smad2在胃癌组织中的表达研究 被引量:1

Smad2 expression in gastric cancer tissue
原文传递
导出
摘要 目的检测Smad2在胃癌组织及正常胃组织的表达情况,探讨其与胃癌发生发展及临床病理学指标的关系。方法收集承德医学院附属医院2012—06—2012—12手术切除经病理证实为胃癌组织60例及正常胃组织30例。应用免疫组织化学法、蛋白质印迹法检测30例正常胃组织与60例胃癌组织Smad2蛋白的表达。结果60例胃癌组织中Smad2蛋白的阳性表达80%,30例正常胃组织标本中阳性率为47%,癌组织远低于正常胃组织组织中的表达,P〈O.05;Smadl蛋白的相对含量在30例正常胃组织为0.33±0.05,在60例胃癌组织为0.78±0.05,两者比较差异有统计学意义,P〈0.05。结论Smad2在胃癌中表达异常,Smad2蛋白的异常表达可能是胃癌发生的一个重要因素,并且与胃癌临床病理特征有着密切的关系。 OBJECTIVE To detect Smad2 expression in gastric cancer tissue and normal gastric tissue and explore its relationship with gastric cancer development and clinical pathology index. METHODS The immune histochemicai method and Western blotting technology to detect 30 cases of normal gastric tissue and 60 cases of gastric cancer tissue Smad2 protein expression. RESULTS Sixty cases of gastric cancer tissues Smad2 protein positive expression of 80%, positive rate was 47% in 30 cases of normal gastric tissue specimens, the expression of the cancer is far lower than the normal gastric tissue tissue (P〈0.05); The relative content of Smadl protein in 30 cases of normal gastric tissue is 0. 33±0. 05, in 60 cases of gastric cancer tissue is 0.78±0.05, the more significant differences (P〈0.05). CONCLUSION Smad2 abnormal expression in gastric cancer, Smad2 abnormal expression of protein may be an important factor of gastric cancer, and has close relation with the clinicopathological features of gastric cancer.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2015年第B22期36-37,48,共3页 Chinese Journal of Cancer Prevention and Treatment
关键词 胃癌 SMAD2 免疫组化 蛋白质印迹法 gastric carcinoma Smad2 Western blotting
  • 相关文献

参考文献4

  • 1Wiegman EM,Blaese MA,Loefier H,et al. TGFbeta-1 dependent fast stimulation of ATM and p53 phosphorylation following ex- posure to ionizing radiation does not involve TGFbeta-receptor I signaling[J]. Radiother Oneol,2007,83(3) :289-295.
  • 2Jianbo Yue, Kathleen M, Mulder. Transforming owth faetor-B signal transduction in epithelial cells[J], fPharmaeology& Ther- apeutics, 2001,91 .. 1-34.
  • 3沈卫东,刘鹏飞,刘兵团,项斌,张伟.TGF-β1和Smad2在胃癌中的表达及意义[J].世界华人消化杂志,2012,20(14):1238-1241. 被引量:9
  • 4Feng XH,Derynck R. Specificity and versatility in TGF-B signa- ling through Smads[J]. Annu Rev Cell Dev Biol, 2005,21: 659- 693.

二级参考文献15

  • 1王勇,许建明.转化生长因子β-Smad信号通路与结肠癌研究进展[J].中华肿瘤防治杂志,2008,15(13):1036-1039. 被引量:9
  • 2肖业臣,黄亚东,李校堃,苏志坚.肿瘤中TGFβ1/Smads信号通路的研究进展[J].肿瘤防治研究,2006,33(8):616-618. 被引量:9
  • 3Todorovic-Rakovic N, Milovanovic J, Nikolie- Vukosavljevi4 D. TGF-β and its coreceptors in cancer- ogenesis: an overview. Biomark Med 2011; 5:855-863.
  • 4Brase JC, Johannes M, Mannsperger H, Faith M, Metzger J, Kacprzyk LA, Andrasiuk T, Gade S, Meister M, Sirma H, Sauter G, Simon R, Schlomm T, Beissbarth T, Korf U, Kuner R, Sultmann H. TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling. BMC Cancer 2011; 11:507.
  • 5Gulubova M, Manolova I, Ananiev J, Julianov A, Yovchev Y, Peeva K. Role of TGF-betal, its receptor TGFbetaRII, and Smad proteins in the progression of colorectal cancer. Int J Colorectal Dis 2010; 25:591-599.
  • 6Hsu YC, Chen MJ, Yu YM, Ko SY, Chang CC. Sup- pression of TGF-β1/SMAD pathway and extracelluu- lar matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid. Arch Dermatol Res 2010; 302:717-724.
  • 7Ijichi H, Ikenoue T, Kato N, Mitsuno Y, Togo G, Kato J, Kanai F, Shiratori Y, Omata M. Systematic analysis of the TGF-beta-Smad signaling pathway in gastrointestinal cancer cells. Biochem Biophys Res Commun 2001; 289:350-357.
  • 8Yu C, Liu Y, Huang D, Dai Y, Cai G, Sun J, Xu T, Tian Y, Zhang X. TGF-β1 mediates epithelial to mesenchymal transition via the TGF-β/Smad path- way in squamous cell carcinoma of the head and neck. Oncol Rep 2011; 25:1581-1587.
  • 9Halder SK, Cho YJ, Datta A, Anumanthan G, Ham AJ, Carbone DP, Datta PK. Elucidating the mecha- nism of regulation of transforming growth factor Type II receptor expression in human lung cancer cell lines. Neoplasia 2011; 13:912-922.
  • 10Reinholz MM, An MW, Johnsen SA, Subramaniam M, Suman VJ, Ingle JN, Roche PC, Spelsberg TC. Differential gene expression of TGF beta inducible early gene (TIEG), Smad7, Smad2 and Bard1 in nor- mal and malignant breast tissue. Breast Cancer Res Treat 2004; 86:75-88.

共引文献8

同被引文献8

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部